On 24th-25th of September 2015 Artem Andrianov, CEO of Cyntegrity, speaks on 20th DGGF International Meeting in Ulm, Germany. DGGF (German Society for Good Research Practice) is a platform to discuss quality management in pharma world. The CEO of Cyntegrity Artem Andrianov speaks about experience of application of [...]
Quality Risk Management as A Survival Kit: From Idea to Implementation Cyntegrity is happy to present a new article at DIA global Forum written by by Randy Ramin-Wright and Artem Andrianov. The article addresses such questions as: what in embracing of RBM one should start with, [...]
The new page with the list of Key Risk Indicators (KRIs) available in Cyntegrity's RBM Cloud Solution appeared on our web-site: KRI modules. Each of the module consist from the number of specified, validated and proven KRIs. All of them are CFR 21 part 11 compliant. Each [...]
An article written by Seb Murray using his specific business-friendly and concise style about Cyntegrity and its founders: "The evolution of clinical trials, with increases in globalization, study complexity and technological capabilities, means there is a need to bring innovative approaches to drug development. Artem Andrianov, a [...]
Cyntegrity's CEO Artem Andrianov to speak on the Germany ePharma day in Munich. The topic of the presentation is Practical methods how to master the new EU Clinical Trials Regulation with risk-based monitoring (RbM) See conference's program here. The event is focused on the new EU regulation [...]
On 15th of April 2015 Artem Andrianov speaks on 8th DIA Clinical Forum, which is conducted this year together with DIA EuroMeeting. The Annual Clinical Forum occurs this year on 14-15th of April 2015 in Paris, France. In comparison to DIA EuroMeeting, it is [...]
In Applied Clinical Trials journal appeared an article, which investigates the question of site screening due diligence and how it can improve patient dropout rates - "RbM Data Reveals Site Screening Due Diligence Improves Patient Dropout and Retention". The investigations for the article were done applying [...]
Cyntegrity brings the innovative risk based monitoring technology to New York. Besides the Silicon Valley in California, New York City has become a real hot spot for innovation from around the globe. Alone New York has 1.5 times larger GDP comparing to Saudi Arabia [...]
Dear Customers, Partners, Friends! Please note in January 2015 Cyntegrity has moved its Operations Office from: Tal Str 4, 65719 Hofheim to (new): Münsterer Str. 49 65719 Hofheim The new office is brighter and bigger in space, has better infrastructure. This will allow the further [...]
Today we are happy to announce that Cyntegrity together with PPH plus, the Institute of Biostatistics and Mathematical Modeling at the Goethe University, and the Fraunhofer Institute have just launched an innovative 1.5 year project for the evaluation and optimization of Risk-based Monitoring. The aim [...]
